Stay updated with breaking news from Nasdaq Blph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Rating) from a sell rating to a hold rating in a report issued on Wednesday morning. A number of other brokerages have also recently issued reports on BLPH. Laidlaw started coverage on shares of Bellerophon Therapeutics in a research note on Tuesday, May 9th. They issued […]
Bellerophon Therapeutics (NASDAQ:BLPH – Get Rating) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday. BLPH has been the topic of a number of other reports. HC Wainwright restated a “buy” rating and issued a $30.00 price target […]
Last Patient Completed Blinded Treatment in REBUILD Phase 3 Trial for INOpulse®; Pivotal Top-line Data Expected in Mid-2023 WARREN, N.J., May 15, 2023 ...
Laidlaw initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Rating) in a research note published on Tuesday, The Fly reports. The firm issued a buy rating on the biotechnology company’s stock. BLPH has been the topic of a number of other reports. HC Wainwright reiterated a buy rating and issued a $30.00 price […]
StockNews.com upgraded shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Rating) from a sell rating to a hold rating in a research report report published on Friday morning. Separately, HC Wainwright reissued a buy rating and set a $30.00 target price on shares of Bellerophon Therapeutics in a research note on Tuesday, April 4th. Bellerophon Therapeutics […]